These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 38863391)
21. Emerging Biomarkers for Predicting Clinical Outcomes in Patients with Heart Disease. Pál K; Mănescu IB; Lupu S; Dobreanu M Life (Basel); 2023 Jan; 13(1):. PubMed ID: 36676179 [TBL] [Abstract][Full Text] [Related]
22. Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability. Olejarz W; Łacheta D; Kubiak-Tomaszewska G Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486345 [TBL] [Abstract][Full Text] [Related]
23. Research on the correlation between activating transcription factor 3 expression in the human coronary artery and atherosclerotic plaque stability. Peng J; Le CY; Xia B; Wang JW; Liu JJ; Li Z; Zhang QJ; Zhang Q; Wang J; Wan CW BMC Cardiovasc Disord; 2021 Jul; 21(1):356. PubMed ID: 34320932 [TBL] [Abstract][Full Text] [Related]
24. The role of OX40L and ICAM-1 in the stability of coronary atherosclerotic plaques and their relationship with sudden coronary death. Wang Y; Sun X; Xia B; Le C; Li Z; Wang J; Huang J; Wang J; Wan C BMC Cardiovasc Disord; 2019 Nov; 19(1):272. PubMed ID: 31783796 [TBL] [Abstract][Full Text] [Related]
25. Association of trimethylamine N-oxide with coronary atherosclerotic burden in patients with non-ST-segment elevation myocardial infarction. Bin Waleed K; Lu Y; Liu Q; Zeng F; Tu H; Wei Y; Xu S; Zhang Z; Rongfeng Y; Fan A; Altaf A; Chang J; Wang L Medicine (Baltimore); 2020 Jul; 99(27):e20794. PubMed ID: 32629663 [TBL] [Abstract][Full Text] [Related]
26. Differential associations between blood biomarkers of inflammation, oxidation, and lipid metabolism with varying forms of coronary atherosclerotic plaque as quantified by coronary CT angiography. Bamberg F; Truong QA; Koenig W; Schlett CL; Nasir K; Butler J; Kurtz E; Nikolaou K; Hoffmann U; Januzzi JL Int J Cardiovasc Imaging; 2012 Jan; 28(1):183-92. PubMed ID: 21222039 [TBL] [Abstract][Full Text] [Related]
28. Mode of death, frequency of healed and acute myocardial infarction, number of major epicardial coronary arteries severely narrowed by atherosclerotic plaque, and heart weight in fatal atherosclerotic coronary artery disease: analysis of 889 patients studied at necropsy. Roberts WC; Potkin BN; Solus DE; Reddy SG J Am Coll Cardiol; 1990 Jan; 15(1):196-203. PubMed ID: 2136873 [TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory Therapy for Coronary Atherosclerotic Heart Disease: Unanswered Questions Behind Existing Successes. Ma J; Chen X Front Cardiovasc Med; 2020; 7():631398. PubMed ID: 33598482 [TBL] [Abstract][Full Text] [Related]
30. Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study. Solbu MD; Mjøen G; Mark PB; Holdaas H; Fellström B; Schmieder RE; Zannad F; Herrington WG; Jardine AG Nephrol Dial Transplant; 2018 Jan; 33(1):102-112. PubMed ID: 27798199 [TBL] [Abstract][Full Text] [Related]
31. Procalcitonin is an independent predictor for coronary atherosclerotic burden in patients with stable coronary artery disease. Kurtul A; Elcik D Int J Cardiol; 2017 Jun; 236():61-64. PubMed ID: 28256322 [TBL] [Abstract][Full Text] [Related]
32. Blood levels of inflammatory and destructive biomarkers in coronary atherosclerosis of different severity. Ragino YI; Chernjavski AM; Polonskaja YV; Tchimbal SY; Redjkin DA; Semaeva EV; Kashtanova EV; Voevoda MI Bull Exp Biol Med; 2010 Oct; 149(5):587-90. PubMed ID: 21165393 [TBL] [Abstract][Full Text] [Related]
33. Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound. Gao WQ; Feng QZ; Li YF; Li YX; Huang Y; Chen YM; Yang B; Lu CY BMC Cardiovasc Disord; 2014 May; 14():60. PubMed ID: 24886532 [TBL] [Abstract][Full Text] [Related]
34. Effect of Dapagliflozin on Ventricular Remodeling and Prognosis in Patients with Coronary Atherosclerotic Heart Disease Undergoing Percutaneous Coronary Intervention. Ye L; Wang K; Sheng H; Shi X; Yan L Altern Ther Health Med; 2024 Apr; 30(4):204-208. PubMed ID: 37944964 [TBL] [Abstract][Full Text] [Related]
35. The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemia. Cao YX; Liu HH; Sun D; Jin JL; Xu RX; Guo YL; Wu NQ; Zhu CG; Li S; Zhang Y; Sun J; Li JJ Atherosclerosis; 2018 Oct; 277():7-14. PubMed ID: 30170223 [TBL] [Abstract][Full Text] [Related]
36. Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV. Douglas PS; McCallum S; Lu MT; Umbleja T; Fitch KV; Foldyna B; Zanni MV; Fulda ES; Bloomfield GS; Fichtenbaum CJ; Overton ET; Aberg JA; Malvestutto CD; Burdo TH; Arduino RC; Ho KS; Yin MT; Ribaudo HJ; Grinspoon SK AIDS; 2023 Mar; 37(3):423-434. PubMed ID: 36525544 [TBL] [Abstract][Full Text] [Related]
37. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. Koenig W Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367 [TBL] [Abstract][Full Text] [Related]
38. Predictive Value of Limb Artery Indices and Endothelial Functional Tests for the Degree of Coronary Artery Stenosis in a Diabetic Population. Wang Z; Chen Y; Lv S; Sun Z; Lu X; Huang L; Li L Int J Gen Med; 2021; 14():2343-2349. PubMed ID: 34113164 [TBL] [Abstract][Full Text] [Related]
39. Effects of ergometrine (ergonovine) on the isolated atherosclerotic heart of the cholsterol-fed rabbit. KARP D; RINZLER SH; TRAVELL J Br J Pharmacol Chemother; 1960 Jun; 15(2):333-44. PubMed ID: 14404556 [TBL] [Abstract][Full Text] [Related]